Bullous pemphigoid: An immune disorder related to aging

ML Deotto, A Spiller… - Experimental and …, 2022 - spandidos-publications.com
Bullous pemphigoid (BP) is the most frequent subepidermal autoimmune blistering disease
and is caused by autoantibodies directed against two principal antigens of the …

[PDF][PDF] The association between neurological diseases, malignancies and cardiovascular comorbidities among patients with bullous pemphigoid: Case-control study in …

A Kalińska-Bienias, E Kowalczyk, P Jagielski… - Advances in Clinical …, 2019 - ruj.uj.edu.pl
Background. Bullous pemphigoid (BP) is the most common autoimmune bullous disease
associated with higher mortality and coexisting comorbidities. The strongest relationship has …

[PDF][PDF] Long-term oral prednisolone exposure in primary care for bullous pemphigoid: population-based study

MSM Persson, KE Harman, KS Thomas… - British Journal of …, 2021 - bjgp.org
Background Oral prednisolone is the mainstay treatment for bullous pemphigoid, an
autoimmune blistering skin disorder affecting older people. Treatment with moderate-to-high …

[HTML][HTML] Anatomical and energy characteristics of charcoal made from five species

S Nisgoski, WLE Magalhães, FRR Batista… - Acta …, 2014 - SciELO Brasil
Charcoal is an important energy raw material and its properties are influenced by the wood's
anatomical and chemical composition and the production process. The aim of this study was …

[HTML][HTML] Factors Influencing the Clinical Course of Bullous Pemphigoid among Geriatric Patients: A Pilot Study

P Mazan, A Lesiak, I Bednarski… - Medicina, 2024 - mdpi.com
Background and Objectives: Bullous pemphigoid (BP) is the most common autoimmune
blistering disease affecting mainly elderly patients. Still, little is known about the …

Bullous pemphigoid and diabetes mellitus: Are we missing the larger picture?

S Geller, N Kremer, T Zeeli, E Sprecher - Journal of the American Academy …, 2018 - jaad.org
We recently studied a group of 114 patients with newly diagnosed BP who were hospitalized
and treated at our institution between 2008 and 2014. 4 We identified 38 patients with BP …

On which evidence can we rely when prescribing off-label methotrexate in dermatological practice?–a systematic review with GRADE approach

AM van Huizen, FM Vermeulen, CMJM Bik… - Journal of …, 2022 - Taylor & Francis
If an authorized drug is prescribed for a use that is not described in the Summary of Product
Characteristics, this is defined as 'off-label use.'Methotrexate is often used off-label for …

A monocentric retrospective observational study of comorbidities in patients affected by autoimmune bullous diseases

M Ferranti, G Gobbo, GT Cicogna, M Alaibac - in vivo, 2020 - iv.iiarjournals.org
Background/Aim: Autoimmune bullous diseases (AIBDs) of the skin and mucosae include a
heterogeneous group of chronic diseases, which could be associated with various …

Metformin in skin diseases

D Kadylak, K Polak, K Wojciechowska… - Dermatology Review …, 2021 - termedia.pl
Metformin is the most widely used oral antidiabetic drug in the world. It is the first-line drug in
type 2 diabetes, where its inhibiting effect on hepatic glucose production, increasing muscle …

Penfigoide e esquemas terapêuticos

LG Ferreira - 2023 - repositorio.ul.pt
Introdução: O penfigoide é uma dermatose bolhosa autoimune, que afeta, maioritariamente,
indivíduos idosos, sendo caracterizado por várias variantes clínicas. Atualmente, os …